×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Blood-Brain Barrier
mechanism
1,899 words
KG: ent-phen-a31f2491
2026-03-31
evidence:strong
mechanism
mechanisms
alzheimers
parkinsons
published
Contents
Blood-Brain Barrier
⚙
Mechanism Info
Name
Blood-Brain Barrier
Category
evidence:strong
Summary
Comprehensive pathway page covering BBB structure, transport mechanisms, dysfunction in AD/PD, and therapeutic delivery strategies
Knowledge Graph
Related Hypotheses (30)
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Aquaporin-4 Polarization Rescue
Score: 0.51
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
SASP-Mediated Complement Cascade Amplification
Score: 0.70
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Closed-loop tACS targeting EC-II SST interneurons to block t
Score: 0.70
Closed-loop focused ultrasound targeting EC-II SST interneur
Score: 0.70
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67
Beta-frequency entrainment therapy targeting PV interneuron-
Score: 0.67
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
p38α Inhibitor and PRMT1 Activator Combination to Restore Ph
Score: 0.61
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener
Score: 0.61
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.60
Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60
HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43
Score: 0.60
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.59
Show 25 more
Related Analyses (30)
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · completed
CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed
Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed
Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed
What delivery mechanisms can achieve therapeutically relevan
drug delivery · failed
What brain concentrations of SCFAs are achieved via oral pro
pharmacokinetics · failed
Do bacterial curli amyloids cross the blood-brain barrier to
neurodegeneration · completed
Do SCFAs directly modulate α-synuclein aggregation in vivo a
neurodegeneration · completed
What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Show 25 more
Related Experiments (30)
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.46
SAHA@LIPO-ANG2 therapeutic efficacy in 5xFAD mice
validation · proposed · Score: 0.90
iPSC-derived endothelial cell iron uptake with RLS CSF expos
exploratory · proposed · Score: 0.90
In vivo BBB transport of LPS-carrying bEVs
validation · proposed · Score: 0.85
qPCR and western blot analysis of microvascular functional m
exploratory · proposed · Score: 0.85
s:** - Compare brain penetration in FcRn+/+ vs FcRn-/- mice
falsification · proposed · Score: 0.46
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
s:** - ALOX15 overexpression in healthy astrocytes should be
falsification · proposed · Score: 0.46
s:** - Compare uptake with/without magnetic particles using
falsification · proposed · Score: 0.46
Proposed experiment from debate on Perivascular spaces and g
falsification · proposed · Score: 0.46
4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.46
AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.46
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.46
Blood-Based Biomarker Panel for Early AD Detection
clinical · proposed · Score: 0.46
Blood-Brain Barrier Aging and Neurodegeneration — From Leaka
validation · proposed · Score: 0.46
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.46
CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.46
Mechanism: Selective Vulnerability of Dopaminergic Neurons i
validation · proposed · Score: 0.46
Cytochrome Therapeutics
clinical · proposed · Score: 0.46
Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.46
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46
Microbiome-Gut-Brain Axis in Alzheimer's Disease — mechanism
clinical · proposed · Score: 0.46
Migraine Cortical Hyperexcitability and Alzheimer's Disease
clinical · proposed · Score: 0.46
Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.46
NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.46
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.46
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.46
Show 25 more